Probable functions and remobilisation of calcium oxalates inMusa L.

The occurrence and distribution of calcium oxalate crystals were investigated in the young and ageing structures of Musa L. cultivars. The calcium oxalate crystals were tested histochemically and examined using light microscopy. The studies revealed the presence of varying forms of the crystals includingintra-amylar, solitary and raphide bundles in the different tissues and organs. Remobilization and redistribution of the crystals were observed following senescence in all the cultivars investigated. The usefulness of these observations in understanding the functions and fate of calcium oxalate crystals in plants are highlighted

Mitotic index studies on edible cocoyams (Xanthosoma and Colocasia spp.)

Mitotic index studies were carried out on three cultivars of Xanthosoma and four cultivars of Colocasia. Young healthy roots (about 15 mm) were collected at 2 hourly intervals from 6:00 am to 8:00 pm. Root tips were fixed in 1:3 ethanol : acetic acid for 24 h and stored in 70% ethanol prior to squashing in FLP orcein. Microscopic counts showed that the dynamics of mitosis varied slightly between the two groups of cultivars. The peak of metaphase remained between 12:00 noon and 2:00 pm for most of cultivars butone (NCY 00Sa), which had its metaphase rising to a peak between 2:00 and 4:00 pm. This suggests that the best time to harvest root samples for optimum metaphase is immediately before 12:00 noo

ESTIMATION OF SHEAR STRENGTH PARAMETERS OF LATERITIC SOILS USING ARTIFICIAL NEURAL NETWORK

This research work seeks to develop models for predicting the shear strength parameters (cohesion and angle of friction) of lateritic soils in central and southern areas of Delta State using   artificial neural network modeling technique. The application of these models will help reduce cost and time in acquiring geotechnical data needed for both design and construction in the study area. A total of eighty-three (83) soil samples were collected from various locations in Delta State of Nigeria.  The geotechnical soil properties were determined in accordance with British Standards.  The range of the angle of internal friction and cohesion obtained from the tests are 2 to 43 degrees and 3 to 82 kN/m2 respectively. The optimum artificial neural network architecture network was found to be 3-9-1, that is three inputs, nine hidden layer nodes, and one output node for cohesion. While, the angle of friction had an optimal network geometry of 3-11-1, that is three inputs, eleven hidden layer nodes, and one output node. The results of the coefficient of determination and root mean square showed that the artificial neural network method outperforms some selected empirical formulae in the prediction of shear strength parameters.  http://dx.doi.org/10.4314/njt.v35i2.

NOMA: A Preventable “Scourge” of African Children

Noma is a serious orofacial gangrene originating intraorally in the gingival-oral mucosa complex before spreading extraorally to produce a visibly destructive ulcer. Although cases of noma are now rarely reported in the developed countries, it is still prevalent among children in third world countries, notably in sub-Sahara Africa, where poverty, ignorance, malnutrition, and preventable childhood infections are still common. This review summarizes historical, epidemiological, management, and research updates on noma with suggestions for its prevention and ultimate global eradication. The global annual incidence remains high at about 140,000 cases, with a mortality rate exceeding 90% for untreated diseases. Where the patients survive, noma defects result in unsightly facial disfigurement, intense scarring, trismus, oral incompetence, and social alienation. Although the etiology has long been held to be infectious, a definitive causal role between microorganisms cited, and noma has been difficult to establish. The management of noma with active disease requires antibiotics followed by reconstructive surgery. Current research efforts are focused towards a comprehensive understanding of the epidemiology, and further elucidation of the microbiology and pathogenesis of noma

Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

Background Some high-income countries have deployed fourth doses of COVID-19 vaccines, but the clinical need, effectiveness, timing, and dose of a fourth dose remain uncertain. We aimed to investigate the safety, reactogenicity, and immunogenicity of fourth-dose boosters against COVID-19.Methods The COV-BOOST trial is a multicentre, blinded, phase 2, randomised controlled trial of seven COVID-19 vaccines given as third-dose boosters at 18 sites in the UK. This sub-study enrolled participants who had received BNT162b2 (Pfizer-BioNTech) as their third dose in COV-BOOST and randomly assigned them (1:1) to receive a fourth dose of either BNT162b2 (30 µg in 0·30 mL; full dose) or mRNA-1273 (Moderna; 50 µg in 0·25 mL; half dose) via intramuscular injection into the upper arm. The computer-generated randomisation list was created by the study statisticians with random block sizes of two or four. Participants and all study staff not delivering the vaccines were masked to treatment allocation. The coprimary outcomes were safety and reactogenicity, and immunogenicity (antispike protein IgG titres by ELISA and cellular immune response by ELISpot). We compared immunogenicity at 28 days after the third dose versus 14 days after the fourth dose and at day 0 versus day 14 relative to the fourth dose. Safety and reactogenicity were assessed in the per-protocol population, which comprised all participants who received a fourth-dose booster regardless of their SARS-CoV-2 serostatus. Immunogenicity was primarily analysed in a modified intention-to-treat population comprising seronegative participants who had received a fourth-dose booster and had available endpoint data. This trial is registered with ISRCTN, 73765130, and is ongoing.Findings Between Jan 11 and Jan 25, 2022, 166 participants were screened, randomly assigned, and received either full-dose BNT162b2 (n=83) or half-dose mRNA-1273 (n=83) as a fourth dose. The median age of these participants was 70·1 years (IQR 51·6–77·5) and 86 (52%) of 166 participants were female and 80 (48%) were male. The median interval between the third and fourth doses was 208·5 days (IQR 203·3–214·8). Pain was the most common local solicited adverse event and fatigue was the most common systemic solicited adverse event after BNT162b2 or mRNA-1273 booster doses. None of three serious adverse events reported after a fourth dose with BNT162b2 were related to the study vaccine. In the BNT162b2 group, geometric mean anti-spike protein IgG concentration at day 28 after the third dose was 23 325 ELISA laboratory units (ELU)/mL (95% CI 20 030–27 162), which increased to 37 460 ELU/mL (31 996–43 857) at day 14 after the fourth dose, representing a significant fold change (geometric mean 1·59, 95% CI 1·41–1·78). There was a significant increase in geometric mean anti-spike protein IgG concentration from 28 days after the third dose (25 317 ELU/mL, 95% CI 20 996–30 528) to 14 days after a fourth dose of mRNA-1273 (54 936 ELU/mL, 46 826–64 452), with a geometric mean fold change of 2·19 (1·90–2·52). The fold changes in anti-spike protein IgG titres from before (day 0) to after (day 14) the fourth dose were 12·19 (95% CI 10·37–14·32) and 15·90 (12·92–19·58) in the BNT162b2 and mRNA-1273 groups, respectively. T-cell responses were also boosted after the fourth dose (eg, the fold changes for the wild-type variant from before to after the fourth dose were 7·32 [95% CI 3·24–16·54] in the BNT162b2 group and 6·22 [3·90–9·92] in the mRNA-1273 group).Interpretation Fourth-dose COVID-19 mRNA booster vaccines are well tolerated and boost cellular and humoral immunity. Peak responses after the fourth dose were similar to, and possibly better than, peak responses after the third dose

Enhancing research on plantain, Musa paradisiacal L. through molecular cytogenetics

No Abstract.Nigerian Journal of Genetics Vol. 16&17 2002: pp. 1-

Ploidy Variation in Hybrids from Interploid 3x X 2x Crosses in Musa

Hybrids were obtained after in vitro germination of embryos from interploid crosses between triploid 'French' plantain cultivars (Musa spp. AAB group) 'Ntanga 2' and 'Bobby Tannap' with diploid banana (Ivlusa acuminata subsp. burmannicoidesj 'Calcutta 4'. Cross-pollinated bunches were harvested at full maturity and ripened with acetylene in a room for 4 days. Seeds were extracted from peeled ripe fruits by squashing. Embryos from the seeds were excised aseptically after 2 days and germinated in vitro. Seedlings were subsequently planted in early evaluation trials after acclimatising in the greenhouse. Chromosome counts were carried out on root tips of mature and maiden suckers to determine ploidy levels using a modified squashing technique. Counts showed that two of the hybrids were aneuploids (trisomies) with somatic chromosome number of 2n = 2x + 1 = 23, one hybrid was diploid while the other two were tetraploids. Tetraploids are the most promising hybrids for the genetic improvement of plantains. Diploids are valuable material for further improvement of the plantain genome at this ploidy level. Trisomies provide means for further characterisation of the Musa genome and physical gene mapping in plantain and banana